62123-80-2

Usage

Uses

Used in Pharmaceutical Industry:
ETHYL 3-BROMOBENZOYL FORMATE is used as an intermediate in the synthesis of various pharmaceuticals for its ability to contribute to the formation of complex organic molecules that possess therapeutic properties.
Used in Agrochemical Industry:
In the agrochemical sector, ETHYL 3-BROMOBENZOYL FORMATE is employed as a precursor in the development of compounds that have applications in crop protection and pest management, enhancing agricultural productivity.
Used in Advanced Materials Industry:
ETHYL 3-BROMOBENZOYL FORMATE is utilized as a component in the creation of advanced materials, where its unique chemical structure contributes to the desired properties of these materials, such as improved performance or specific functionalities.
Used as a Reagent in Chemical Reactions:
ETHYL 3-BROMOBENZOYL FORMATE serves as a reagent in various chemical reactions, facilitating the synthesis of a range of organic compounds for diverse applications across different industries.
Used in the Manufacture of Other Organic Compounds:
ETHYL 3-BROMOBENZOYL FORMATE is also used in the production of other organic compounds, highlighting its versatility in organic synthesis and its importance in the chemical industry.

InChI:InChI=1/C10H9BrO3/c1-2-14-10(13)9(12)7-4-3-5-8(11)6-7/h3-6H,2H2,1H3

Upstream product

• 108-36-1 1,3-dibromobenzene 
• 95-92-1 oxalic acid diethyl ester 
• 3132-99-8 m-bromobenzoic aldehyde 
• 64-17-5 ethanol 
• 67-66-3 chloroform 

Downstream Products

• 94163-56-1 Cyclohexyl-<3-brom-phenyl>-glykolsaeure-aethylester 
• 1352419-68-1 rac-(3-bromo-phenyl)-(2-methylpropane-2-sulfinylimino)acetic acid ethyl ester 
• 1352419-69-2 rac-2-amino-2-(3-bromophenyl)-2-cyclopropylethanol 
• 1352420-04-2 C₁₄H₁₃BrF₄N₂O 
• 1352420-03-1 C₁₄H₁₃BrF₄N₂O 
• 1352420-20-2 C₁₄H₁₂BrClF₃NO₂ 
• 1352420-21-3 C₁₄H₁₃BrF₃NO₂ 
• 1352417-08-3 (2S,3R)-N-{3-[5-amino-3-cyclopropyl-2-fluoro-2-(trifluoromethyl)-3,6-dihydro-2H-1,4-oxazin-3-yl]phenyl}-5-cyanopyridine-2-carboxamide 

Relevant academic research and scientific papers

Tris(pentafluorophenyl)borane-Catalyzed Oxygen Insertion Reaction of α-Diazoesters (α-Diazoamides) with Dimethyl Sulfoxide

A tris(pentafluorophenyl)borane-catalyzed oxidation reaction of α-diazoesters (α-diazo amides) with dimethyl sulfoxide has been developed. The reaction proceeds under metal free conditions to afford a series α-ketoesters and α-ketoamides. The synthetic utility of this protocol is demonstrated through synthetic transformations and scaled-up synthesis. (Figure presented.).

Stereoselective Synthesis of Dihydrocoumarins via [1,2]-Phospha-Brook Rearrangement in Three-Component Coupling Reaction of α-Ketoesters, o-Quinone Methides, and Dialkyl Phosphites

A highly regio- and diastereoselective approach for the synthesis of phosphate substituted dihydrocoumarins via Br?nsted base catalyzed [1,2]-phospha-Brook rearrangement is reported. The two-step, one-pot Michael addition of α-phosphonyloxy enolates proceeds by coupling of dialkyl phosphite and α-ketoesters to o-quinone methides, followed by an intramolecular cyclization, providing 3,4-dihydrocoumarin frameworks.

CERAMIDE GALACTOSYLTRANSFERASE INHIBITORS FOR THE TREATMENT OF DISEASE

Described herein are compounds, methods of making such compounds, pharmaceutical compositions and medicaments containing such compounds, and methods of using such compounds to treat or prevent diseases or disorders associated with the enzyme ceramide galactosyltransferase (CGT), such as, for example, lysosomal storage diseases. Examples of lysosomal storage diseases include, for example, Krabbe disease and Metachromatic Leukodystrophy.

Class of large ring heterocyclic compound restraining HCV and manufacturing and uses thereof

The invention relates to a class of compounds that inhibit HCV. The compounds are represented by Formula A. The invention also relates to preparation and pharmaceutical use of the compounds.

DERIVATIVES OF 4-(2-AMINO-1-HYDROXYETHYL)PHENOL AS AGONISTS OF THE β2 ADRENERGIC RECEPTOR

The present invention provides a compound of formula (I) wherein: R1 is a group selected from -CH2OH, -NHC(O)H and R2 is a hydrogen atom; or R1 together with R2 form the group -NH-C(O)-CH=CH- wherein the nitrogen atom is bound to the carbon atom in the phenyl ring holding R1 and the carbon atom is bound to the carbon atom in the phenyl ring holding R2; R3 is selected from hydrogen and halogen atoms or groups selected from -SO-R5, -SO2- R5, -NH-CO-NH2, -CO-NH2, hydantoino, C1-4alkyl, C1-4alkoxy and -SO2NR5R6; R4 is selected from hydrogen atoms, halogen atoms and C1-4alkyl groups; R5 is a C1-4alkyl group or C3-8 cycloalkyl; R6 is independently selected from hydrogen atoms and C1-4alkyl groups; n, p and q are independently 0, 1 , 2, 3 or 4; m and s are independently 0, 1 , 2 or 3; r is 0, 1 or 2; with the provisos that: at least one of m and r is not 0; the sum n+m+p+q+r+s is 7, 8, 9, 10, 11 , 12 or 13; the sum q+r+s is 2, 3, 4, 5 or 6 or a pharmaceutically-acceptable salt, solvate or stereoisomer thereof.